Abra H. Shen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Abra H. Shen has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Derrick C. Wan
Hagey Laboratory for Pediatric Regenerative Medicine Stanford University School of Medicine Stanford California USA
3 shared publications - Alessandra L. Moore
Brigham and Women's Hospital, Boston, MA, USA
2 shared publications - Deshka S. Foster
Hagey Laboratory for Pediatric Regenerative Medicine, Division of Plastic and Reconstructive Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA
2 shared publications - Geoffrey C. Gurtner
Department of Surgery, University of Arizona College of Medicine, Tucson, AZ 85724, USA
2 shared publications - Gerlinde Wernig
Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
2 shared publications - Heather E. Desjardins-Park
Stanford Univ, Sch Med, Stanford, CA 94305 USA
2 shared publications
Latest Publications
- 24 October 2026
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 124, 71-80
Bridging policy and practice: Recommendations for parental support in plastic surgery
- 24 October 2026
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 124, 71-80
Bridging policy and practice: Recommendations for parental support in plastic surgery
- 1 September 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13  (609) , eabb3312
JUN promotes hypertrophic skin scarring via CD36 in preclinical in vitro and in vivo models
JUN drives scarring by modifying the roles of fibroblast subpopulations, and JUN antagonism via CD36 may represent an antiscarring therapy.
- 1 September 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13  (609) , eabb3312
JUN promotes hypertrophic skin scarring via CD36 in preclinical in vitro and in vivo models
JUN drives scarring by modifying the roles of fibroblast subpopulations, and JUN antagonism via CD36 may represent an antiscarring therapy.
- Top Cited Papers
- 23 April 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 372  (6540) , 362-+
Preventing Engrailed-1 activation in fibroblasts yields wound regeneration without scarring
Regeneration without scarring: Wounds in adult mammals typically heal by forming fibrotic scars. Mascharak et al. found that a specific population of skin fibroblasts ( Engrailed-1 lineage–negative fibroblasts) activate expression of Engrailed-1 and turn on profibrotic cellular programs in response to local tissue mechanics in wounds (see the Perspective by Konieczny and Naik). When mechanical signaling was inhibited in these cells (using either genetic deletion or small-molecule inhibition), skin wounds in mice no longer formed scars but instead healed by regeneration, restoring skin with normal hair follicles and glands, extracellular matrix, and mechanical strength. Science , this issue p. eaba2374 ; see also p. 346
- 23 April 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 372  (6540) , 362-+
Top Cited PapersPreventing Engrailed-1 activation in fibroblasts yields wound regeneration without scarring
Regeneration without scarring: Wounds in adult mammals typically heal by forming fibrotic scars. Mascharak et al. found that a specific population of skin fibroblasts ( Engrailed-1 lineage–negative fibroblasts) activate expression of Engrailed-1 and turn on profibrotic cellular programs in response to local tissue mechanics in wounds (see the Perspective by Konieczny and Naik). When mechanical signaling was inhibited in these cells (using either genetic deletion or small-molecule inhibition), skin wounds in mice no longer formed scars but instead healed by regeneration, restoring skin with normal hair follicles and glands, extracellular matrix, and mechanical strength. Science , this issue p. eaba2374 ; see also p. 346
- Top Cited Papers
- 1 October 2019
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 83  (4S) , S59-S64
Radiation-Induced Skin Fibrosis
Radiotherapy (RT) has become an indispensable part of oncologic treatment protocols for a range of malignancies. However, a serious adverse effect of RT is radiodermatitis; almost 95% of patients develop moderate to severe skin reactions following radiation treatment. In the acute setting, these can be erythema, desquamation, ulceration, and pain. Chronically, soft tissue atrophy, alopecia, and stiffness can be noted. Radiodermatitis can delay oncologic treatment protocols and significantly impair quality of life. There is currently a paucity of effective treatment options and prevention strategies for radiodermatitis. Importantly, recent preclinical and clinical studies have suggested that fat grafting may be of therapeutic benefit, reversing detrimental changes to soft tissue following RT. This review outlines the damaging effects of RT on the skin and soft tissue as well as discusses available treatment options for radiodermatitis. Emerging strategies to mitigate detrimental, chronic radiation-induced changes are also presented.
- 1 October 2019
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 83  (4S) , S59-S64
Top Cited PapersRadiation-Induced Skin Fibrosis
Radiotherapy (RT) has become an indispensable part of oncologic treatment protocols for a range of malignancies. However, a serious adverse effect of RT is radiodermatitis; almost 95% of patients develop moderate to severe skin reactions following radiation treatment. In the acute setting, these can be erythema, desquamation, ulceration, and pain. Chronically, soft tissue atrophy, alopecia, and stiffness can be noted. Radiodermatitis can delay oncologic treatment protocols and significantly impair quality of life. There is currently a paucity of effective treatment options and prevention strategies for radiodermatitis. Importantly, recent preclinical and clinical studies have suggested that fat grafting may be of therapeutic benefit, reversing detrimental changes to soft tissue following RT. This review outlines the damaging effects of RT on the skin and soft tissue as well as discusses available treatment options for radiodermatitis. Emerging strategies to mitigate detrimental, chronic radiation-induced changes are also presented.
- 21 June 2019
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 26  (11) , 3502-3509
Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer
Background The prognostic significance of low-volume residual nodal disease following neoadjuvant chemotherapy (NAC) is unknown.
- 21 June 2019
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 26  (11) , 3502-3509
Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer
Background The prognostic significance of low-volume residual nodal disease following neoadjuvant chemotherapy (NAC) is unknown.
- Open Access
- 6 March 2019
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 24  (6) , 864-865
Reflecting on the Human Connection
A medical student describes a relationship with a cancer patient, the privilege of human connections in life, and the lessons learned from a first experience with death.
- 6 March 2019
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 24  (6) , 864-865
Open AccessReflecting on the Human Connection
A medical student describes a relationship with a cancer patient, the privilege of human connections in life, and the lessons learned from a first experience with death.
- 1 December 2018
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 28  (12) , 1463-1470
Intraoperative Ventilation Patterns in Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery
Background: The purpose of this study was to examine ventilation patterns, including tidal volume (TV) and positive end-expiratory pressure (PEEP) selection in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass or laparoscopic sleeve gastrectomy. Methods: Intraoperative ventilation data, including TV and PEEP, were abstracted from the electronic anesthesia record (Metavision) at Brigham and Women's Hospital. Ideal body weight (IBW) was calculated using the Devine formula, and TV per kg IBW was calculated for each patient. Results: The mean TV delivered per kg IBW was 7.35 ± 1.07 mL/kg, and 24% (281/1186) of patients received TVs of >8 mL/kg IBW. The median PEEP applied was 5.5 ± 0.6 cmH2O, and 87% (1035/1186) of patients received PEEP >0 cmH2O. There was significant variation in both TV and PEEP selection. Conclusions: The significant variation in TV per kg IBW as well as in PEEP values at our institution may reflect the lack of well-established guidelines for intraoperative ventilation. Many patients in this study received inappropriately large TVs (>8 mL/kg IBW), which may be due to calculation of TVs based on total body weight rather than IBW. Patients of shorter stature and higher body mass index appear to be at higher risk for ventilation with inappropriately large TVs.
- 1 December 2018
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 28  (12) , 1463-1470
Intraoperative Ventilation Patterns in Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery
Background: The purpose of this study was to examine ventilation patterns, including tidal volume (TV) and positive end-expiratory pressure (PEEP) selection in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass or laparoscopic sleeve gastrectomy. Methods: Intraoperative ventilation data, including TV and PEEP, were abstracted from the electronic anesthesia record (Metavision) at Brigham and Women's Hospital. Ideal body weight (IBW) was calculated using the Devine formula, and TV per kg IBW was calculated for each patient. Results: The mean TV delivered per kg IBW was 7.35 ± 1.07 mL/kg, and 24% (281/1186) of patients received TVs of >8 mL/kg IBW. The median PEEP applied was 5.5 ± 0.6 cmH2O, and 87% (1035/1186) of patients received PEEP >0 cmH2O. There was significant variation in both TV and PEEP selection. Conclusions: The significant variation in TV per kg IBW as well as in PEEP values at our institution may reflect the lack of well-established guidelines for intraoperative ventilation. Many patients in this study received inappropriately large TVs (>8 mL/kg IBW), which may be due to calculation of TVs based on total body weight rather than IBW. Patients of shorter stature and higher body mass index appear to be at higher risk for ventilation with inappropriately large TVs.
- 26 September 2018
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 25  (7) , 1590-1598
Adherence to oral chemotherapy: Challenges and opportunities
There is very little data on the effect of combining methods to better predict and improve oral antineoplastic adherence in cancer patients. The goal of this study was to evaluate the effectiveness of an intensive pharmacist intervention at the beginning of oral antineoplastic therapy versus nurse-led control group on adherence. This was a prospective, randomized, open-label controlled trial performed in a single center hematology/oncology outpatient service to compare the effectiveness of repetitive pharmacist educational intervention on adherence rates measured at four and eight weeks after prescribing oral antineoplastic medication compared to a nurse-led control group. Both groups included investigator pill counts and self-report adherence questionnaires. Two-hundred patients were enrolled between 2009 and 2015. Fourteen of the 101 (14%) patients in the pharmacist group and 7 (7%) of the 99 patients in the nurse-led control group dropped out (p = 0.166). The majority of patients who remained in the study were 90–100% adherent to oral antineoplastic therapy in both groups. The pharmacist group slightly underperformed at Pill Count 2, possibly due to barriers for non-adherence. Statistically significant correlations associated with non-adherence were forgetfulness (p = 0.009), wanting to avoid side effects (p = 0.02), feeling depressed or overwhelmed (p = 0.032), or falling asleep before taking medication (p = 0.048) in both groups. The combination of pill count and patient self-report adherence is a way of improving oral antineoplastic adherence. However, significant barriers to adherence were identified such as forgetfulness, wanting to avoid side effects, feeling depressed or overwhelmed, and falling asleep before taking medications.
- 26 September 2018
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 25  (7) , 1590-1598
Adherence to oral chemotherapy: Challenges and opportunities
There is very little data on the effect of combining methods to better predict and improve oral antineoplastic adherence in cancer patients. The goal of this study was to evaluate the effectiveness of an intensive pharmacist intervention at the beginning of oral antineoplastic therapy versus nurse-led control group on adherence. This was a prospective, randomized, open-label controlled trial performed in a single center hematology/oncology outpatient service to compare the effectiveness of repetitive pharmacist educational intervention on adherence rates measured at four and eight weeks after prescribing oral antineoplastic medication compared to a nurse-led control group. Both groups included investigator pill counts and self-report adherence questionnaires. Two-hundred patients were enrolled between 2009 and 2015. Fourteen of the 101 (14%) patients in the pharmacist group and 7 (7%) of the 99 patients in the nurse-led control group dropped out (p = 0.166). The majority of patients who remained in the study were 90–100% adherent to oral antineoplastic therapy in both groups. The pharmacist group slightly underperformed at Pill Count 2, possibly due to barriers for non-adherence. Statistically significant correlations associated with non-adherence were forgetfulness (p = 0.009), wanting to avoid side effects (p = 0.02), feeling depressed or overwhelmed (p = 0.032), or falling asleep before taking medication (p = 0.048) in both groups. The combination of pill count and patient self-report adherence is a way of improving oral antineoplastic adherence. However, significant barriers to adherence were identified such as forgetfulness, wanting to avoid side effects, feeling depressed or overwhelmed, and falling asleep before taking medications.
- 5 February 2018
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 22  (2) , 10
Complex Regional Pain Syndrome, Current Concepts and Treatment Options
Complex regional pain syndrome (CRPS) refers to a chronic pain condition that is characterized by progressively worsening spontaneous regional pain without dermatomal distribution. The symptomatology includes pain out of proportion in time and severity to the inciting event. The purpose of this review is to present the most current information concerning epidemiology, diagnosis, pathophysiology, and therapy for CRPS.
- 5 February 2018
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 22  (2) , 10
Complex Regional Pain Syndrome, Current Concepts and Treatment Options
Complex regional pain syndrome (CRPS) refers to a chronic pain condition that is characterized by progressively worsening spontaneous regional pain without dermatomal distribution. The symptomatology includes pain out of proportion in time and severity to the inciting event. The purpose of this review is to present the most current information concerning epidemiology, diagnosis, pathophysiology, and therapy for CRPS.
- 1 April 2016
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 34  (4) , 168.e11-168.e20
The experience of patients with early-stage testicular cancer during the transition from active treatment to follow-up surveillance
- 1 April 2016
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 34  (4) , 168.e11-168.e20
The experience of patients with early-stage testicular cancer during the transition from active treatment to follow-up surveillance